Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 15278

1.

Meta-analysis of the effects of intensive rearing environments on the performance and welfare of broiler chickens.

Averós X, Estevez I.

Poult Sci. 2018 Jun 19. doi: 10.3382/ps/pey243. [Epub ahead of print]

PMID:
29924356
3.

Polyethyleneimine modification of aluminum hydroxide nanoparticle enhances antigen transportation and cross-presentation of dendritic cells.

Dong H, Wen ZF, Chen L, Zhou N, Liu H, Dong S, Hu HM, Mou Y.

Int J Nanomedicine. 2018 Jun 7;13:3353-3365. doi: 10.2147/IJN.S164097. eCollection 2018.

4.

Influenza viral vectors expressing two kinds of HA proteins for bivalent vaccines against clade 2.3.4.4 and clade 2.3.2.1 H5 HPAIVs.

Hou G, Li J, Wang Y, Wang S, Peng C, Yu X, Jin J, Jiang W.

Sci Rep. 2018 Jun 19;8(1):9327. doi: 10.1038/s41598-018-27722-5.

5.

Hexavalent vaccines: increasing options for policy-makers and providers. A review of the data supporting interchangeability (substitution with vaccines containing fewer antigens) and mixed schedules from the same manufacturer.

Dolhain J, Janssens W, Mesaros N, Hanssens L, Fierens F.

Expert Rev Vaccines. 2018 Jun 19:1-12. doi: 10.1080/14760584.2018.1419070. [Epub ahead of print]

PMID:
29920121
6.

Synergy in anti-malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density.

Sherrard-Smith E, Sala KA, Betancourt M, Upton LM, Angrisano F, Morin MJ, Ghani AC, Churcher TS, Blagborough AM.

Elife. 2018 Jun 19;7. pii: e35213. doi: 10.7554/eLife.35213.

7.

Adherence with and completion of recommended hepatitis vaccination schedules among adults in the United States.

Trantham L, Kurosky SK, Zhang D, Johnson KD.

Vaccine. 2018 Jun 13. pii: S0264-410X(18)30788-6. doi: 10.1016/j.vaccine.2018.05.111. [Epub ahead of print]

PMID:
29909136
8.

Evaluation of carbopol as an adjuvant on the effectiveness of progressive atrophic rhinitis vaccine.

Zhang J, Wang M, Zhou N, Shen Y, Li Y.

Vaccine. 2018 Jun 13. pii: S0264-410X(18)30839-9. doi: 10.1016/j.vaccine.2018.06.023. [Epub ahead of print]

PMID:
29909135
9.

Post-PEGylated and crosslinked polymeric ssRNA nanocomplexes as adjuvants targeting lymph nodes with increased cytolytic T cell inducing properties.

Lou B, De Beuckelaer A, Dakwar GR, Remaut K, Grooten J, Braeckmans K, De Geest BG, Mastrobattista E, De Koker S, Hennink WE.

J Control Release. 2018 Jun 14. pii: S0168-3659(18)30345-6. doi: 10.1016/j.jconrel.2018.06.010. [Epub ahead of print]

PMID:
29908893
10.

Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models.

Grees M, Sharbi-Yunger A, Evangelou C, Baumann D, Cafri G, Tzehoval E, Eichmüller SB, Offringa R, Utikal J, Eisenbach L, Umansky V.

Oncoimmunology. 2018 Mar 26;7(7):e1445457. doi: 10.1080/2162402X.2018.1445457. eCollection 2018.

PMID:
29900058
11.

Development, Interlaboratory Evaluations, and Application of a Simple, High-Throughput Shigella Serum Bactericidal Assay.

Nahm MH, Yu J, Weerts HP, Wenzel H, Tamilselvi CS, Chandrasekaran L, Pasetti MF, Mani S, Kaminski RW.

mSphere. 2018 Jun 13;3(3). pii: e00146-18. doi: 10.1128/mSphere.00146-18. Print 2018 Jun 27.

12.

A novel Ebola virus antibody-dependent cell-mediated cytotoxicity (Ebola ADCC) assay.

Singh K, Marasini B, Chen X, Spearman P.

J Immunol Methods. 2018 Jun 9. pii: S0022-1759(17)30519-7. doi: 10.1016/j.jim.2018.06.002. [Epub ahead of print]

PMID:
29894746
13.

Intranasal inoculate of influenza virus vaccine against lethal virus challenge.

Fan X, Su Q, Qiu F, Yi Y, Shen L, Jia Z, Liang P, Zou Y, Bi S.

Vaccine. 2018 Jul 5;36(29):4354-4361. doi: 10.1016/j.vaccine.2018.05.075. Epub 2018 Jun 4.

PMID:
29880240
14.

Gallid herpesvirus 3 SB-1 strain as a recombinant viral vector for poultry vaccination.

Sadigh Y, Powers C, Spiro S, Pedrera M, Broadbent A, Nair V.

NPJ Vaccines. 2018 May 28;3:21. doi: 10.1038/s41541-018-0056-6. eCollection 2018.

15.

Effect of prior vaccination on carriage rates of Streptococcus pneumoniae in older adults: A longitudinal surveillance study.

Branche AR, Yang H, Java J, Wiltse-Holden J, Topham DJ, Peasley M, Frost MR, Nahm MH, Falsey AR.

Vaccine. 2018 Jul 5;36(29):4304-4310. doi: 10.1016/j.vaccine.2018.05.107. Epub 2018 Jun 2.

PMID:
29871816
16.

Defective T-cell immunity in hepatitis B virus infection: why therapeutic vaccination needs a helping hand.

Maini MK, Pallett LJ.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):192-202. doi: 10.1016/S2468-1253(18)30007-4. Review.

PMID:
29870733
17.

Bacterial Adherence and Dwelling Probability: Two Drivers of Early Alveolar Infection by Streptococcus pneumoniae Identified in Multi-Level Mathematical Modeling.

Santos G, Lai X, Eberhardt M, Vera J.

Front Cell Infect Microbiol. 2018 May 15;8:159. doi: 10.3389/fcimb.2018.00159. eCollection 2018.

18.

Tuberculosis vaccine candidate: Characterization of H4-IC31 formulation and H4 antigen conformation.

Deshmukh SS, Magcalas FW, Kalbfleisch KN, Carpick BW, Kirkitadze MD.

J Pharm Biomed Anal. 2018 Aug 5;157:235-243. doi: 10.1016/j.jpba.2018.05.048. Epub 2018 May 31.

19.

Update on non-typeable Haemophilus influenzae-mediated disease and vaccine development.

Jalalvand F, Riesbeck K.

Expert Rev Vaccines. 2018 Jun 18:1-10. doi: 10.1080/14760584.2018.1484286. [Epub ahead of print]

PMID:
29863956
20.

Clinical Expectations for Better Influenza Virus Vaccines-Perspectives from the Young Investigators' Point of View.

Mohn KG, Zhou F.

Vaccines (Basel). 2018 May 26;6(2). pii: E32. doi: 10.3390/vaccines6020032. Review.

Supplemental Content

Loading ...
Support Center